BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osmak G, Baulina N, Kiselev I, Favorova O. MiRNA-Regulated Pathways for Hypertrophic Cardiomyopathy: Network-Based Approach to Insight into Pathogenesis. Genes (Basel) 2021;12:2016. [PMID: 34946964 DOI: 10.3390/genes12122016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tamargo J, Tamargo M, Caballero R. Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline. Expert Opin Investig Drugs 2022. [PMID: 36062808 DOI: 10.1080/13543784.2022.2113374] [Reference Citation Analysis]
2 Pisklova M, Osmak G, Favorova O. Regulation of SMAD Signaling Pathway by miRNAs Associated with Myocardial Fibrosis: In silico Analysis of Target Gene Networks. Biochemistry Moscow 2022;87:832-838. [DOI: 10.1134/s0006297922080144] [Reference Citation Analysis]